Axonics Inc. (AXNX) Price to Earnings Ratio

Corporate emblem and logo of Axonics Inc. (AXNX)

The following quotes illustrate the price action of Axonics, Inc. (AXNX), a developer of sacral neuromodulation systems. The business relies on lifelong user lock-in to its software and the support of a medtech behemoth, with the indicator standing at -0.60. Axonics, Inc. (AXNX) dominates the market through innovative rechargeable stimulators that provide significant pricing power. However, potential growth is constrained by patent litigation and possible product quality issues.

Axonics, Inc (AXNX) Price to Earnings Ratio: for the period 07/04/2022 - 11/11/2026

Comprehensive metric breakdowns and analytics for Axonics Modulation Technologies (AXNX)

- price and consensus price forecast:
Stock Price axonics.com|AXNX - Price Target Chart
- market capitalization details:
Market Value Axonics, Inc.|AXNX - Enterprise Value
- book capitalization information:
Net Assets per Share Axonics|AXNX - Company Net Assets|Market Capitalization to Net Assets axonics.com|AXNX - Company Total Assets
- debt and solvency information:
Debt to Capital Axonics, Inc.|AXNX - Long-Term Debt to Capital|Short-Term Debt to Capital Ratio Axonics, Inc|AXNX - Company Total Debt|Debt to Net Assets Ratio Axonics, Inc.|AXNX - Company Long-Term Debt|Company Current Liabilities Axonics|Immediate Liquidity axonics.com
- earnings and market multiples details:
AXNX - Net Profit|Net Profit Forecast Axonics, Inc.|AXNX - P/E Multiple|Market Cap to Projected Earnings Axonics Inc.|AXNX - PEG Multiple|Enterprise Value to EBITDA Ratio Axonics, Inc.|AXNX - Operating profit EBITDA|Net earnings per share (EPS TTM) Axonics|AXNX - Earnings per share for the last twelve months|Year-over-year earnings per share growth for the last twelve months axonics.com|AXNX - Net earnings per share growth this year|Expected earnings per share trend next year Axonics, Inc.
General company analysis:axonics.com - AXNX
Original product of axonics.com

Investors are assessing the potential of Axonics, Inc. (AXNX) through the lens of profit generation efficiency relative to market value. This ratio determines the investment payback period based on the current net earnings per share. The 12-month trailing (ttm) P/E dynamics of Axonics, Inc. (AXNX) help identify whether the asset is overvalued or faces a risk of stagnation. The stability of this metric confirms confidence in the management team, which has successfully commercialized urological systems. This enhances the issuer's attractiveness ahead of the upcoming merger with a medical behemoth.

Analysis of competing companies

P/E Multiple bostonscientific.com|Price to Earnings Ratio Edwards Lifesciences Corporation (EW)|Price to Earnings Ratio RMD (ResMed Inc)|P/E Multiple PODD (OmniPod)|Business Payback Period Zimmer Biomet (ZBH)|COO: Price to Earnings Ratio|Market Cap to Net Income ALGN|GMED: P/E Multiple|Market Cap to Earnings TransMedics Organ Care System (TMDX)|ATEC (ATEC Spine) - P/E Multiple|Price to Earnings Multiple AORT (Artivion Corp)|Price to Earnings Ratio ENOV (Enovis Corporation)|IART (integralife.com) - Company Value to Net Income|Price to Earnings Ratio Establishment Labs Holdings Inc. ESTA|BBNX - Price to Earnings Ratio|Iradimed - P/E Multiple|Market Cap to Earnings Embecta Health|TNDM: P/E Multiple|Price to Earnings Multiple AXGN|SIBN (SI-BONE) - P/E Multiple|Orthofix Medical (OFIX) - Business Payback Period|P/E Multiple BVS|Price to Earnings Ratio orthopediatrics.com KIDS|P/E Multiple TMCI (Treace Medical Concepts)|P/E Multiple blade.com SRTA|CARL - Price to Earnings Ratio|RXST: Price to Earnings Ratio|CLPT (clearpointneuro.com) - Price to Earnings Ratio|Stereotaxis Corporation - Company Value to Net Income|STIM (Neuronetics, Inc.) - P/E Multiple|Market Cap to Earnings sightsciences.com SGHT|Price to Earnings Ratio Orchestra BioMed, Inc. (OBIO)|anikatherapeutics.com (ANIK) - Market Cap to Net Income Ratio|InspireMD Corp - Price to Earnings Ratio|P/E Multiple Jin Medical International Ltd. ZJYL|Vivani - P/E Multiple|Business Payback Period Xtant Medical Holdings XTNT|NeuroOne Medical Technologies Corporation (NMTC) - Price to Earnings Ratio|Market Cap to Net Income MODD (Modular Medical, Inc.)|Price to Earnings Ratio Myomo, Inc|Price to Earnings Ratio Envoy Medical Inc (COCH)|P/E Multiple VVOS|NVNO - Market Cap to Earnings|Price to Earnings Ratio Sintx Technologies, Inc. SINT|TNON: Price to Earnings Multiple|LFWD: Price to Earnings Ratio|Autonomix Medical, Inc. - Market Price to Net Income Ratio|IVF: P/E Multiple|bonebiologics.com (BBLG) - P/E Multiple|Price to Earnings Ratio BIOL|Price to Earnings Multiple DYNT (Dynatronics Corp.)|Price to Earnings Ratio Paragon 28, Inc. (FNA)|INVO - Market Cap to Earnings